Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach
暂无分享,去创建一个
Nader I. Al-Dewik | H. Rifai | Sawsan G Mohammed | Sawsan Mohammed | BalaSubramani Gattu Linga | Thomas Farrell | M. W. Qoronfleh
[1] S. Gaikwad,et al. Newborn Screening in Developing Countries: The Need of the Hour , 2024, Cureus.
[2] A. Astegno,et al. Biochemical and structural impact of two novel missense mutations in cystathionine beta-synthase gene associated with homocystinuria. , 2024, The Biochemical journal.
[3] Y. Bombard,et al. Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol. , 2024, BMJ open.
[4] K. Cole,et al. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study. , 2024, The Lancet. Oncology.
[5] R. Carrozzo,et al. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia , 2024, Frontiers in oncology.
[6] B. Crompton,et al. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q , 2023, Nature communications.
[7] U. AlAlami,et al. Studying carrier frequency of spinal muscular atrophy in the State of Qatar and comparison to other ethnic groups: Pilot study , 2023, Molecular genetics & genomic medicine.
[8] Anne L. Ersig,et al. Call to Action for Advancing Equitable Genomic Newborn Screening , 2023, Public Health Genomics.
[9] Yuanyuan Gu,et al. Genome Sequencing for Newborn Screening-An Effective Approach for Tackling Rare Diseases. , 2023, JAMA network open.
[10] Zhiyu Peng,et al. Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening , 2023, JAMA network open.
[11] Meshal Almutairi,et al. Knowledge of Cancer Genetics and the Importance of Genetic Testing: A Public Health Study , 2023, Cureus.
[12] J. Savulescu,et al. Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns? , 2023, Pharmacogenomics and personalized medicine.
[13] R. Scott,et al. Genomic newborn screening for rare diseases , 2023, Nature Reviews Genetics.
[14] A. Naeem,et al. MDM2- an indispensable player in tumorigenesis , 2023, Molecular Biology Reports.
[15] E. Schröck,et al. A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children. , 2023, Genetics in medicine : official journal of the American College of Medical Genetics.
[16] H. Pederson,et al. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants , 2023, JAMA network open.
[17] S. Behjati,et al. Diagnostic classification of childhood cancer using multiscale transcriptomics , 2023, Nature Medicine.
[18] A. Patiño-García,et al. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing , 2023, Scientific Reports.
[19] Saskia M. J. Hopman,et al. Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm , 2023, JAMA network open.
[20] P. Rahimi,et al. Biomarkers and Corresponding Biosensors for Childhood Cancer Diagnostics , 2023, Sensors.
[21] Arun K. Ramani,et al. The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations , 2022, Nature Cancer.
[22] M. Cazzola. Risk stratifying MDS in the time of precision medicine. , 2022, Hematology. American Society of Hematology. Education Program.
[23] K. Wimmer,et al. High yield of surveillance in patients diagnosed with constitutional mismatch repair deficiency , 2022, Journal of Medical Genetics.
[24] D. Malkin,et al. Genetic predisposition to cancers in children and adolescents , 2022, Current opinion in pediatrics.
[25] D. Vears,et al. Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screening , 2022, Journal of genetic counseling.
[26] E. Shagimardanova,et al. Application of Multigene Panels Testing for Hereditary Cancer Syndromes , 2022, Biology.
[27] Erin L Marcotte,et al. Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care , 2022, Frontiers in Pediatrics.
[28] Shan Jiang. A Scoping Review of Global Guidelines for the Disclosure of Secondary Genomic Findings to Inform the Establishment of Guidelines in China , 2022, China CDC weekly.
[29] A. Biffi,et al. Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy , 2022, Cancers.
[30] H. Okkels,et al. Genetic predisposition & evolutionary traces of pediatric cancer risk: A prospective 5-year population-based genome sequencing study of children with CNS tumors. , 2022, Neuro-oncology.
[31] R. Howell,et al. The Progress and Future of US Newborn Screening , 2022, International journal of neonatal screening.
[32] R. Scott,et al. Newborn Screening by Genomic Sequencing: Opportunities and Challenges , 2022, International journal of neonatal screening.
[33] W. Rashed,et al. Germline De Novo Mutations as a Cause of Childhood Cancer. , 2022, JCO precision oncology.
[34] S. Mueller,et al. TBIO-12. Screening for Cancer Predisposition Syndromes in Pediatric Neuro-Oncology Patients: a Single Institution Experience , 2022, Neuro-Oncology.
[35] P. Kolatkar,et al. Pyridoxine non-responsive R336C mutation alters the molecular properties of cystathionine beta-synthase leading to severe homocystinuria phenotype. , 2022, Biochimica et biophysica acta. General subjects.
[36] D. Parsons,et al. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] N. André,et al. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies , 2022, Cancer discovery.
[38] D. Ritter,et al. Evolution of germline TP53 variant classification in children with cancer. , 2022, Cancer genetics.
[39] L. Walker,et al. Paediatric cancer predisposition syndromes in the genomic age , 2022, Paediatrics and Child Health.
[40] M. Nelen,et al. Towards Next-Generation Sequencing (NGS)-Based Newborn Screening: A Technical Study to Prepare for the Challenges Ahead , 2022, International journal of neonatal screening.
[41] Zhengyan Zhao,et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates , 2022, Orphanet Journal of Rare Diseases.
[42] R. Grubs,et al. Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States , 2022, Journal of genetic counseling.
[43] Alicia R. Martin,et al. Diversity in Genomic Studies: A Roadmap to Address the Imbalance , 2022, Nature Medicine.
[44] S. Kingsmore,et al. Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit , 2022, Frontiers in Pediatrics.
[45] J. Mezey,et al. The QChip1 knowledgebase and microarray for precision medicine in Qatar , 2022, NPJ genomic medicine.
[46] N. Mahlaoui,et al. Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe , 2022, The Lancet regional health. Europe.
[47] Christine Cahaney,et al. Role of Precision Medicine in Pediatric Oncology. , 2022, Pediatric annals.
[48] S. MacFarland,et al. Childhood Cancer Predisposition: An Overview for the General Pediatrician. , 2022, Pediatric annals.
[49] Kathleen F. Mittendorf,et al. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. , 2021, JCO precision oncology.
[50] Katherine M. Tucker,et al. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. , 2021, JAMA oncology.
[51] J. Takita. Molecular Basis and Clinical Features of Neuroblastoma , 2021, JMA Journal.
[52] P. Nathan,et al. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] David C. Jones,et al. The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets , 2021, Cancer discovery.
[54] Aman N. Patel,et al. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing , 2021, Cancer discovery.
[55] Aashish N. Adhikari,et al. The Use of Whole Genome and Exome Sequencing for Newborn Screening: Challenges and Opportunities for Population Health , 2021, Frontiers in Pediatrics.
[56] D. Amor,et al. Principles of Genomic Newborn Screening Programs , 2021, JAMA network open.
[57] D. Koirala,et al. Symptomatic familial adenomatous polyposis in an adolescent: A case report , 2021, International journal of surgery case reports.
[58] R. Kuiper,et al. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel , 2021, Familial Cancer.
[59] S. Pfister,et al. Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations. , 2021, Neuro-oncology practice.
[60] T. Battelino,et al. Next-Generation Sequencing in Newborn Screening: A Review of Current State , 2021, Frontiers in Genetics.
[61] C. Tebbi. Etiology of Acute Leukemia: A Review , 2021, Cancers.
[62] A. Borkhardt,et al. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer , 2021, European Journal of Human Genetics.
[63] M. Gee,et al. Screening of cancer predisposition syndromes , 2021, Pediatric Radiology.
[64] Matthew S. Lebo,et al. Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project , 2021, Genetics in Medicine.
[65] Christine Y. Lu,et al. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights , 2021, Genetics in Medicine.
[66] Floor A. M. Postema,et al. Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study , 2021, Familial Cancer.
[67] N. Schultz,et al. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors , 2021, Nature Cancer.
[68] S. Behjati,et al. Predisposition to cancer in children and adolescents. , 2021, The Lancet. Child & adolescent health.
[69] J. Christodoulou,et al. Newborn bloodspot screening in the time of COVID-19 , 2021, Genetics in Medicine.
[70] N. Tommerup,et al. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes , 2020, PLoS genetics.
[71] Borbala Mifsud,et al. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar , 2020, Life sciences, society and policy.
[72] M. Qoronfleh,et al. Pathway to excellence in cancer care: learning from Qatar's experience , 2020 .
[73] A. Iolascon,et al. Genetic Predisposition to Solid Pediatric Cancers , 2020, Frontiers in Oncology.
[74] M. Cornel,et al. Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide , 2020, Journal of Community Genetics.
[75] M. Durkin,et al. Translating Molecular Technologies into Routine Newborn Screening Practice , 2020, International journal of neonatal screening.
[76] David M. Thomas,et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer , 2020, Nature medicine.
[77] L. Mirabello,et al. Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group. , 2020, JCO precision oncology.
[78] N. J. Gillespie,et al. Genitourinary manifestations of hereditary cancer predisposition syndromes in children , 2020, Translational andrology and urology.
[79] Muneer H Albagshi,et al. Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency Among Children in Eastern Saudi Arabia , 2020, Cureus.
[80] E. Langfelder-Schwind,et al. Bridging the Gap between Scientific Advancement and Real-World Application: Pediatric Genetic Counseling for Common Syndromes and Single-Gene Disorders. , 2020, Cold Spring Harbor perspectives in medicine.
[81] V. Nagy,et al. Genetic predisposition in pediatric oncology , 2020, Medicine and pharmacy reports.
[82] Aman N. Patel,et al. St. Jude Cloud—a Pediatric Cancer Genomic Data Sharing Ecosystem , 2020, bioRxiv.
[83] Y. Bombard,et al. Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment , 2020, Genetics in Medicine.
[84] Aashish N. Adhikari,et al. The role of exome sequencing in newborn screening for inborn errors of metabolism , 2020, Nature Medicine.
[85] S. J. Henley,et al. Pediatric cancer mortality and survival in the United States, 2001‐2016 , 2020, Cancer.
[86] F. Cheng,et al. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors , 2020, Nature Communications.
[87] S. Namayandeh,et al. GLOBAL Leukemia in Children 0-14 Statistics 2018, Incidence and Mortality and Human Development Index (HDI): GLOBOCAN Sources and Methods , 2020, Asian Pacific journal of cancer prevention : APJCP.
[88] David M. Thomas,et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. , 2020, JAMA oncology.
[89] A. Goel,et al. Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: a Systematic Review. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[90] P. Schielen,et al. Introducing and Expanding Newborn Screening in the MENA Region , 2020, International journal of neonatal screening.
[91] E. Steliarova-Foucher,et al. Childhood cancer: Estimating regional and global incidence. , 2020, Cancer epidemiology.
[92] J. Stoll,et al. Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes. , 2019, Gastroenterology & hepatology.
[93] P. Easterbrook,et al. Hepatitis B virus infection in children and adolescents. , 2019, The lancet. Gastroenterology & hepatology.
[94] Gheyath K Nasrallah,et al. Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population , 2019, Journal of inherited metabolic disease.
[95] P. Hainaut,et al. Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome , 2019, Pediatric blood & cancer.
[96] J. Biegel,et al. The genomic landscape of pediatric cancers: Implications for diagnosis and treatment , 2019, Science.
[97] S. Rednam. Updates on progress in cancer screening for children with hereditary cancer predisposition syndromes , 2019, Current opinion in pediatrics.
[98] N. Hawkes. Cancer survival data emphasise importance of early diagnosis , 2019, British Medical Journal.
[99] J. Wise. Genome sequencing of children promises a new era in oncology , 2019, British Medical Journal.
[100] Matthew S. Lebo,et al. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. , 2019, American journal of human genetics.
[101] P. Carter,et al. The Major Causes of Death in Children and Adolescents in the United States. , 2018, The New England journal of medicine.
[102] Gheyath K Nasrallah,et al. In silico and in vivo models for Qatari‐specific classical homocystinuria as basis for development of novel therapies , 2018, Human mutation.
[103] A. Loh,et al. Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours , 2018, npj Genomic Medicine.
[104] R. Siebert,et al. Family-based germline sequencing in children with cancer , 2018, Oncogene.
[105] B. Solomon,et al. Clinical genetics and genomic medicine in Qatar , 2018, Molecular genetics & genomic medicine.
[106] W. Foulkes,et al. Retrospective evaluation of a decision‐support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors , 2018, Pediatric blood & cancer.
[107] M. Abrar,et al. Prevalence of hereditary cancer susceptibility syndromes in children with cancer in a highly consanguineous population. , 2018, Cancer epidemiology.
[108] R. Green,et al. The BabySeq project: implementing genomic sequencing in newborns , 2018, BMC Pediatrics.
[109] Jeremy Michelson. My Diagnostic Odyssey-A Call to Expand Access to Genomic Testing for the Next Generation. , 2018, The Hastings Center report.
[110] E. Parens,et al. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies. , 2018, The Hastings Center report.
[111] Michael C. Heinold,et al. The landscape of genomic alterations across childhood cancers , 2018, Nature.
[112] Xin Zhou,et al. Pan-cancer genome and transcriptome analyses of 1,699 pediatric leukemias and solid tumors , 2018, Nature.
[113] Z. Memish,et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015 , 2017, Journal of epidemiology and global health.
[114] L. Guerrini-Rousseau,et al. Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome , 2017, Journal of Medical Genetics.
[115] A. Shimamura,et al. Genetic predisposition to hematologic malignancies: management and surveillance. , 2017, Blood.
[116] H. Rehm. A new era in the interpretation of human genomic variation , 2017, Genetics in Medicine.
[117] W. Foulkes,et al. Retinoblastoma and Neuroblastoma Predisposition and Surveillance , 2017, Clinical Cancer Research.
[118] H. Blom,et al. Cysteamine revisited: repair of arginine to cysteine mutations , 2017, Journal of Inherited Metabolic Disease.
[119] Eva Steliarova-Foucher,et al. International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.
[120] S. Plon,et al. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr , 2017, Clinical Cancer Research.
[121] W. Chung,et al. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients , 2017, Journal of Genetic Counseling.
[122] Floor A. M. Postema,et al. Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study , 2017, BMJ Open.
[123] Stuart J. Andrews,et al. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations , 2016, Genome Medicine.
[124] P. Rosenberg,et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort , 2016, Cancer.
[125] M. Szego,et al. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? , 2016, Journal of Medical Ethics.
[126] J. Shendure,et al. The power of multiplexed functional analysis of genetic variants , 2016, Nature Protocols.
[127] R. Gibbs,et al. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. , 2016, JAMA oncology.
[128] Julie O. Culver,et al. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. , 2016, Cancer genetics.
[129] R. Kuiper,et al. Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool. , 2016, European journal of medical genetics.
[130] J. Botkin,et al. Whole Genome Sequencing and Newborn Screening , 2016, Current Genetic Medicine Reports.
[131] A. McGuire,et al. Potential Psychosocial Risks of Sequencing Newborns , 2016, Pediatrics.
[132] Wendy K Chung,et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing , 2015, Genetics in Medicine.
[133] Li Ding,et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.
[134] G. Leverger,et al. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[135] Nallasivam Palanisamy,et al. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. , 2015, JAMA.
[136] F. Saletta,et al. Genetic causes of cancer predisposition in children and adolescents. , 2015, Translational pediatrics.
[137] J. Loeber,et al. Current status of newborn screening worldwide: 2015. , 2015, Seminars in perinatology.
[138] J. Shohet,et al. Neuroblastoma: molecular pathogenesis and therapy. , 2015, Annual review of medicine.
[139] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[140] B. Monk,et al. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2. , 2014, Gynecologic oncology.
[141] T. Sokolsky,et al. Development of DNA Confirmatory and High-Risk Diagnostic Testing for Newborns Using Targeted Next-Generation DNA Sequencing , 2014, Genetics in Medicine.
[142] Natasha F Bonhomme,et al. Newborn screening: adapting to advancements in whole-genome sequencing. , 2014, Genetic testing and molecular biomarkers.
[143] F. Westermann,et al. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies , 2014, Oncogene.
[144] N. Rahman,et al. Mainstreaming genetic testing of cancer predisposition genes. , 2014, Clinical medicine.
[145] S. Berry. Newborn screening. , 2014, Clinics in perinatology.
[146] V. Mitev,et al. APC promoter 1B deletion in familial polyposis—implications for mutation‐negative families , 2014, Clinical genetics.
[147] Heather L. Mulder,et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.
[148] Wylie Burke,et al. Genetic Tests: Clinical Validity and Clinical Utility , 2014, Current protocols in human genetics.
[149] H. Levy. Newborn screening: the genomic challenge , 2014, Molecular genetics & genomic medicine.
[150] A. Bredenoord,et al. The Right to an Open Future Concerning Genetic Information , 2014, The American journal of bioethics : AJOB.
[151] F. Couch,et al. Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2 , 2014, Human mutation.
[152] Evan E Eichler,et al. Properties and rates of germline mutations in humans. , 2013, Trends in genetics : TIG.
[153] M. Pourfarzam,et al. Newborn Screening for inherited metabolic disorders; news and views , 2013, Journal of Research in Medical Sciences.
[154] Elliot Stieglitz,et al. Genetic predispositions to childhood leukemia , 2013, Therapeutic advances in hematology.
[155] H. Saal,et al. Ethical and Policy Issues in Genetic Testing and Screening of Children , 2013, Pediatrics.
[156] F. Couch,et al. A guide for functional analysis of BRCA1 variants of uncertain significance , 2012, Human mutation.
[157] Zahra Saberi,et al. Neurofibromatosis type I (von Recklinghausen's disease): A family case report and literature review , 2012, Dental research journal.
[158] S. Steinberg,et al. Rate of de novo mutations, father’s age, and disease risk , 2012, Nature.
[159] Li Ding,et al. The Pediatric Cancer Genome Project , 2012, Nature Genetics.
[160] M. Järvelin,et al. Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. , 2011, Schizophrenia bulletin.
[161] J. Shendure,et al. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data , 2011, Nature Reviews Genetics.
[162] Ching-Hon Pui,et al. Challenging issues in pediatric oncology , 2011, Nature Reviews Clinical Oncology.
[163] P. Babyn,et al. Imaging of cancer predisposition syndromes in children. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.
[164] A. Shlien,et al. Copy number variations and cancer susceptibility , 2010, Current opinion in oncology.
[165] D. Bercovich,et al. Familial adenomatous polyposis , 2009, Orphanet journal of rare diseases.
[166] G. Draper,et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004 , 2009, British Journal of Ophthalmology.
[167] D. Marsden,et al. Newborn Screening , 2009, Critical reviews in clinical laboratory sciences.
[168] Uri Tabori,et al. Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome , 2008, Proceedings of the National Academy of Sciences.
[169] Dieter Niederacher,et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.
[170] D. Malkin,et al. Hereditary cancer predisposition in children: Genetic basis and clinical implications , 2006, International journal of cancer.
[171] K K Matthay,et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[172] K. Offit,et al. Hereditary cancer predisposition syndromes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[173] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[174] Edwin W. Naylor,et al. Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress , 2003 .
[175] S. Pakakasama,et al. Genetic predisposition and screening in pediatric cancer. , 2002, Pediatric clinics of North America.
[176] B. Therrell. U.S. newborn screening policy dilemmas for the twenty-first century. , 2001, Molecular genetics and metabolism.
[177] W F Bodmer,et al. The ABC of APC. , 2001, Human molecular genetics.
[178] M. Kambouris,et al. Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). , 2001, Journal of tropical pediatrics.
[179] B. Hankey,et al. The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[180] D. Gutmann,et al. Loss of neurofibromatosis type I (NFI) gene expression in pheochromocytomas from patients without NFI , 1994, Genes, chromosomes & cancer.
[181] G. Brodeur. The NF1 gene in myelopoiesis and childhood myelodysplastic syndromes. , 1994, The New England journal of medicine.
[182] J. Akatsuka,et al. Neurofibromatosis type 1 and childhood cancer , 1993, Cancer.
[183] B. Gallie,et al. A simplified scheme for genetic counseling in retinoblastoma. , 1987, Journal of pediatric ophthalmology and strabismus.
[184] Stephen H. Friend,et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.
[185] D. Gutmann,et al. Optic Pathway Gliomas in Neurofibromatosis Type 1 , 2018, Journal of child neurology.
[186] Meghan C Towne,et al. Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals. , 2018, JIMD reports.
[187] Allison P. Heath,et al. Data Commons to Support Pediatric Cancer Research. , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[188] J. Bohlius,et al. HIV-associated malignancies in children , 2017, Current opinion in HIV and AIDS.
[189] C. Isaacs,et al. How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[190] R. Guthrie,et al. The introduction of newborn screening for phenylketonuria , 2009, European Journal of Pediatrics.
[191] Newborn screening: toward a uniform screening panel and system. , 2006, Genetics in medicine : official journal of the American College of Medical Genetics.
[192] P. Kleihues,et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.
[193] C. Pratt,et al. Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. , 1994, Medical and pediatric oncology.
[194] M. Bisgaard,et al. Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate , 1994, Human mutation.